Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1- profile in a TLR4-dependent manner (2018)
- Authors:
- Wanderley, Carlos W.
- Colon, David F.
- Luiz, Joao Paulo Mesquita
- Oliveira, Francisco F.
- Viacava, Paula R.
- Leite, Caio A.
- Pereira, Janaina A.
- Silva, Camila M.
- Silva, Cassia R.
- Silva, Rangel L.
- Hernandez, Cesar A. Speck
- Mota, Jose M.
- Alves Filho, José Carlos Farias
- Lima-Júnior, Roberto C.
- Cunha, Thiago Mattar
- Cunha, Fernando de Queiroz
- USP affiliated authors: ALVES FILHO, JOSÉ CARLOS FARIAS - FMRP ; CUNHA, THIAGO MATTAR - FMRP ; CUNHA, FERNANDO DE QUEIROZ - FMRP
- Unidade: FMRP
- DOI: 10.1158/0008-5472.can-17-3480
- Subjects: ANTINEOPLÁSICOS; IMUNOLOGIA CELULAR; NEOPLASIAS; MACRÓFAGOS
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Cancer Research
- ISSN: 0008-5472
- Volume/Número/Paginação/Ano: v. 78, n. 20, p. 5891-5900, 2018
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
- Licença: other-oa
-
ABNT
WANDERLEY, Carlos W. et al. Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1- profile in a TLR4-dependent manner. Cancer Research, v. 78, n. 20, p. 5891-5900, 2018Tradução . . Disponível em: https://doi.org/10.1158/0008-5472.can-17-3480. Acesso em: 01 jun. 2024. -
APA
Wanderley, C. W., Colon, D. F., Luiz, J. P. M., Oliveira, F. F., Viacava, P. R., Leite, C. A., et al. (2018). Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1- profile in a TLR4-dependent manner. Cancer Research, 78( 20), 5891-5900. doi:10.1158/0008-5472.can-17-3480 -
NLM
Wanderley CW, Colon DF, Luiz JPM, Oliveira FF, Viacava PR, Leite CA, Pereira JA, Silva CM, Silva CR, Silva RL, Hernandez CAS, Mota JM, Alves Filho JCF, Lima-Júnior RC, Cunha TM, Cunha F de Q. Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1- profile in a TLR4-dependent manner [Internet]. Cancer Research. 2018 ; 78( 20): 5891-5900.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1158/0008-5472.can-17-3480 -
Vancouver
Wanderley CW, Colon DF, Luiz JPM, Oliveira FF, Viacava PR, Leite CA, Pereira JA, Silva CM, Silva CR, Silva RL, Hernandez CAS, Mota JM, Alves Filho JCF, Lima-Júnior RC, Cunha TM, Cunha F de Q. Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1- profile in a TLR4-dependent manner [Internet]. Cancer Research. 2018 ; 78( 20): 5891-5900.[citado 2024 jun. 01 ] Available from: https://doi.org/10.1158/0008-5472.can-17-3480 - Differential regulation of oxidative stress and cytokine production by endothelin ETA and ETB receptors in superoxide anion-induced inflammation and pain in mice
- Bosentan, a mixed endothelin receptor antagonist, inhibits superoxide anion-induced pain and inflammation in mice
- Curcumin inhibits superoxide anion-induced pain-like behavior and leukocyte recruitment by increasing Nrf2 expression and reducing NF-kB activation
- 15d-PGJ2-loaded nanocapsules ameliorate experimental gout arthritis by reducing pain and inflammation in a PPAR-gamma-sensitive manner in mice
- Diosmin reduces chronic constriction injury-induced neuropathic pain in mice
- Probucol attenuates lipopolysaccharide-induced leukocyte recruitment and inflammatory hyperalgesia: effect on NF-кB activation and cytokine production
- The PI3Kγ/AKT signaling pathway mediates peripheral antinociceptive action of dipyrone
- Targeting IL-33/ST2 signaling: regulation of immune function and analgesia
- Probucol attenuates overt pain-like behavior and carrageenan-induced inflammatory hyperalgesia and leukocyte recruitment by inhibiting NF-кB activation and cytokine production without antioxidant effects
- Pericytes modulate myelination in the central nervous system
Informações sobre o DOI: 10.1158/0008-5472.can-17-3480 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
